↓ Skip to main content

Dove Medical Press

The efficacy and safety of aflibercept and conbercept in diabetic macular edema

Overview of attention for article published in Drug Design, Development and Therapy, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
39 Mendeley
Title
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
Published in
Drug Design, Development and Therapy, October 2018
DOI 10.2147/dddt.s177192
Pubmed ID
Authors

Siwei Cai, Qianhui Yang, Xiaorong Li, Yan Zhang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 18%
Student > Master 4 10%
Student > Doctoral Student 3 8%
Student > Bachelor 3 8%
Student > Postgraduate 3 8%
Other 4 10%
Unknown 15 38%
Readers by discipline Count As %
Medicine and Dentistry 12 31%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Biochemistry, Genetics and Molecular Biology 3 8%
Social Sciences 2 5%
Agricultural and Biological Sciences 1 3%
Other 3 8%
Unknown 14 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2021.
All research outputs
#8,595,692
of 25,523,622 outputs
Outputs from Drug Design, Development and Therapy
#646
of 2,273 outputs
Outputs of similar age
#142,216
of 355,040 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 61 outputs
Altmetric has tracked 25,523,622 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,273 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.